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Background
Recruiting participants to trials can be extremely diffi-
cult. Estimates of just how difficult vary but around half
of trials fail to recruit their original target sample size.
Poor recruitment can lead to an underpowered study,
which may report clinically relevant effects to be statisti-
cally non-significant. A non-significant finding increases
the risk that an effective intervention will be abandoned
before its true value is established, or that there will be
a delay in demonstrating this value while more trials or
meta-analyses are done.
Why is recruitment a problem?
Reviews of barriers and enablers to recruitment do exist,
as do case studies linked to individual trials. Trial proce-
dures that are time consuming for both clinicians and
patient will adversely affect recruitment, as will trial pro-
tocols that are a long way from current routines. Not
knowing how many people are likely to be eligible for
the trial before starting it will lead to disappointment
known as Lasagna’s Law: potential participants vanish as
soon as the trial starts.
What recruitment strategies have been used
already?
Systematic reviews have found promising strategies for
increasing recruitment to trials: telephone reminders;
requiring potential participants to opt-out of being con-
tacted by the trial team regarding taking part in a trial,
rather than them having to opt-in, and open designs.
However, recruitment strategies are rarely linked expli-
citly to context-specific barriers and enablers to recruit-
ment, something that could reasonably be expected to
lead to a more reproducible basis for strategy selection.
Many strategies remain inadequately evaluated.
What might help?
Trialists and methodologists should work together to
link recruitment barriers and enablers to recruitment
strategies. Trialists should include evaluations of their
recruitment strategies in their trials and funders should
support this because the number of interventions that
have been rigorously evaluated in the context of a real
trial is low. Creating registers of individuals interested in
research participation would ease recruitment problems
for many trials, especially if linked to other clinical data-
bases to support inclusion criteria checks and recruit-
ment planning. Methodological work around thinking of
a trial as a product that needs to be marketed to partici-
pants, rather than assuming the value of the trial is
obvious to all, is worthy of further investigation.
Conclusions
Trialists and methodologists can help themselves and
future recipients of healthcare innovations by making
better use of existing research evidence on recruitment
a n db ye x p l i c i t l ya i m i n gt op l u gg a p si nt h i se v i d e n c e
where they exist.
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